Omega Fund Management

Omega Fund Management as of June 30, 2021

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 21 positions in its portfolio as reported in the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Common Stock (REPL) 31.8 $192M 5.0M 38.42
Morphic Holding Common Stock (MORF) 16.8 $101M 1.8M 57.39
Kronos Bio Common Stock 15.1 $91M 3.8M 23.95
Ikena Oncology Common Stock (IKNA) 5.2 $32M 2.2M 14.04
Gossamer Bio Common Stock (GOSS) 4.5 $27M 3.3M 8.12
Spruce Biosciences Common Stock (SPRB) 4.0 $24M 2.2M 11.21
Immunic Common Stock (IMUX) 3.6 $22M 1.8M 12.26
Paratek Pharmaceuticals Common Stock 2.9 $18M 2.6M 6.82
Arcutis Biothereapeutics Common Stock (ARQT) 2.8 $17M 624k 27.29
Atea Pharmaceuticals Common Stock (AVIR) 2.7 $16M 747k 21.48
Syros Pharmaceuticals Common Stock 2.1 $12M 2.3M 5.45
Alpine Immune Sciences Common Stock 1.9 $12M 1.3M 9.00
ESSA Pharma Common Stock (EPIX) 1.6 $9.4M 328k 28.57
Checkmate Pharmaceuticals Common Stock 1.3 $8.0M 1.3M 5.96
Omega Alpha SPAC Common Stock 0.8 $5.0M 501k 9.95
Cidara Therapeutics Common Stock 0.7 $4.1M 2.0M 2.02
FibroGen Common Stock 0.6 $3.5M 131k 26.63
ObsEva Common Stock 0.5 $3.0M 999k 3.03
Trevi Therapeutics Common Stock (TRVI) 0.5 $2.8M 1.3M 2.25
Immunocore Holdings Common Stock (IMCR) 0.3 $2.0M 52k 39.04
Jounce Therapeutics Common Stock 0.3 $1.9M 276k 6.80